Contract analysis

I. EXECUTIVE SUMMARY The purpose of this memorandum is to set forth the recommended side letter framework for Cobalt Life Sciences Opportunities Fund I, LP ("CLSO Fund I" or the "Fund"), a Delaware limited partnership to be formed, with a target fund size of $750,000,000 (the "Target Size") and a hard cap of $1,000,000,000 (the "Hard Cap"). The Fund will pursue an opportunistic life-sciences investment strategy, as d

II. BACKGROUND AND CONTEXT A. Fund Overview CLSO Fund I is an opportunistic life-sciences fund pursuing control and significant-minority investments across three primary sectors: (i) Clinical-Stage Therapeutics: Investments in companies with drug candidates in Phase II clinical trials or later stages of development, where the Fund can underwrite de-risked clinical pathways with identifiable regulatory milestones and

III. STANDARD SIDE LETTER CONCESSIONS This Section III describes the categories of side letter concessions that we recommend making available on a standardized basis to qualifying investors, subject to the tiered framework discussed in Section VII. These provisions represent the core menu of terms that CLSO GP should be prepared to offer during negotiations, and they are designed to address the most common institutio

I. Advisory Committee (LPAC) Representation LPAC Composition. As noted in Section II.B, the LPAC will consist of a minimum of three and a maximum of seven members, appointed by CLSO GP. At least one member must be a representative of a non-U.S. LP if aggregate non-U.S. commitments reach $50,000,000. Side Letter Allocation of Seats. LPAC seats are a governance concession that is typically offered to the largest LPs an

IV. INVESTOR-SPECIFIC TERMS — ANCHOR INVESTORS This Section sets forth the detailed analysis of investor-specific side letter terms anticipated for each of the three anchor investors. The analysis for each investor includes: (a) a profile of the investor; (b) a description of the key terms expected to be sought, based on preliminary discussions and market practice; and (c) our recommendations regarding each requested

1. Investor Profile. Full Legal Name: Ironwood Public Employees' Retirement System Type: State pension fund, organized and existing under the laws of the State of Oregon AUM: Approximately $62 billion Primary Contact: Helen Tsao, Director of Private Markets, 900 Capitol Way NE, Suite 400, Salem, Oregon 97301 Anticipated Commitment: $100,000,000, subject to approval by the Ironwood PERS Investment Committee, which is

2. Key Terms Sought. Based on preliminary discussions with Helen Tsao's team and Ironwood PERS's outside counsel, the following terms are expected to be sought: MFN Side Letter. Ironwood PERS will expect full MFN rights, with the broadest possible scope of election. As the largest LP, Ironwood PERS will expect to be the MFN "benchmark" investor, meaning that its side letter effectively sets the ceiling of concessions

3. Analysis and Recommendations. The $100,000,000 commitment from Ironwood PERS represents approximately 13.3% of the Fund's target size. This is a marquee anchor relationship that provides the Fund with substantial first-close capital, a credible institutional anchor investor for marketing purposes, and a relationship that, if successful, could yield follow-on commitments in future Cobalt Life Sciences vintage vehic

1. Investor Profile. Full Legal Name: Northgate Endowment Management LLC Type: Delaware limited liability company; investment arm of a major university endowment AUM: Approximately $8.5 billion Primary Contact: David Park, Senior Portfolio Manager – Life Sciences Allocation, 77 Brattle Street, 4th Floor, Cambridge, Massachusetts 02138 Anticipated Commitment: $50,000,000 Background: Northgate is the external investmen

2. Key Terms Sought. ERISA-Compliant Carve-Out Structure. Although Northgate is itself an endowment investment arm—and therefore not itself an employee benefit plan subject to ERISA—certain of its underlying investment pools may constitute "plan assets" within the meaning of ERISA Section 3(42) and Department of Labor Regulation §2510.3-101. This arises because certain retirement and benefit plans for university empl

3. Analysis and Recommendations. The $50,000,000 commitment from Northgate represents approximately 6.7% of the Fund's target size. While smaller in absolute terms than the Ironwood PERS and Pinnacle commitments, Northgate's participation carries significant signaling value in the life-sciences investor community. University endowments with dedicated life-sciences allocation programs are among the most knowledgeable

1. Investor Profile. Full Legal Name: Pinnacle Insurance Group, Inc. Type: Connecticut corporation; life and annuity insurer General Account AUM: Approximately $28 billion Primary Contact: Rachel Stein, Senior Vice President – Alternative Investments, 500 Asylum Avenue, Hartford, Connecticut 06103 Anticipated Commitment: $75,000,000 Background: Pinnacle is a leading life and annuity insurance company domiciled in Con

2. Key Terms Sought. Insurance Regulatory Compliance Provisions. As a life and annuity insurer regulated by the Connecticut Insurance Department (and potentially other state insurance regulators in states where Pinnacle is licensed), Pinnacle's investment in the Fund is subject to a comprehensive regulatory framework governing the types, amounts, and concentrations of investments that may be held in an insurer's gene